The ZC 25 imprint identifies a prescription oral tablet containing Meloxicam 7.5 mg. Manufactured by Zydus Pharmaceuticals, meloxicam belongs to the nonsteroidal anti-inflammatory drug (NSAID) class and is primarily used to relieve joint pain, swelling, and stiffness caused by arthritis.
4h2 Pill is a white eliptical/oval pill, which is identified as a second-generation antihistamine Cetirizine Hydrochloride 10mg Tablet.
XL-3 is a widely available brand of over the counter (OTC) multi-symptom cold, flu, and allergy medications. Unlike single-ingredient prescription drugs, XL-3 represents a multi-ingredient combination product formulated to treat several upper respiratory symptoms simultaneously, including fever, body aches, nasal congestion, runny nose, and sneezing.
Because XL-3 is marketed in several formulations – most notably standard XL-3 Cold Medicine and XL-3 Xtra Cold & Cough – the exact ingredients, dosages, and active profiles vary by specific product line.
The TV 58 imprint identifies a prescription oral tablet containing Tramadol Hydrochloride 50 mg. Manufactured by Teva Pharmaceuticals USA, tramadol is a centrally acting analgesic categorized as a Schedule IV controlled substance in the United States due to its potential for abuse, physical dependence, and addiction.
The TL 177 imprint identifies a prescription tablet containing Cyclobenzaprine Hydrochloride 10 mg. Cyclobenzaprine is a central-acting skeletal muscle relaxant structurally related to tricyclic antidepressants (TCAs). It is primarily prescribed as an adjunct to rest and physical therapy for the relief of muscle spasms associated with acute, painful musculoskeletal conditions.
The T 258 imprint identifies a combination prescription pain relief tablet containing Hydrocodone Bitartrate (7.5 mg) and Acetaminophen (325 mg). Manufactured by Camber Pharmaceuticals, Inc., this medication belongs to the opioid analgesic combination class and is classified as a Schedule II controlled substance in the United States due to its significant potential for abuse, severe physical dependence, and addiction.
The T 193 imprint identifies a combination prescription pain medication containing Oxycodone Hydrochloride (7.5 mg) and Acetaminophen (325 mg). Distributed by Camber Pharmaceuticals, Inc., this drug belongs to the combination narcotic analgesic class and is categorized as a Schedule II controlled substance in the United States due to its significant potential for abuse, physical dependence, and addiction.
The SG 180 imprint identifies a prescription capsule containing Gabapentin 300 mg, manufactured by ScieGen Pharmaceuticals, Inc. Belonging to the class of medications known as gabapentinoids, gabapentin is widely prescribed to manage neuropathic pain and control specific types of epileptic seizures.
The white pill stamped with the imprint R180 is identified as Tizanidine Hydrochloride 4 mg. Manufactured by Dr. Reddy’s Laboratories (and distributed by various pharmaceutical vendors), it is the generic equivalent of the brand-name skeletal muscle relaxant Zanaflex.
The pill stamped with the imprint TCL 341 is an over-the-counter (OTC) formulation of Extra Strength Acetaminophen 500 mg. Manufactured primarily by Time Cap Labs, Inc. (hence the “TCL” prefix), it serves as a common generic equivalent to brand-name medications such as Tylenol Extra Strength.
The pill imprinted with A80 (or A 8 0), appearing as an orange, oval-shaped (capsule/oblong) soft gelatin capsule, is identified as Progesterone 200 mg.
Manufactured by Amneal Pharmaceuticals, this oral softgel capsule is a bioidentical, micronized form of the naturally occurring female sex hormone progesterone. It is the generic equivalent of the brand-name drug Prometrium.